CO96 Subgroup Analysis of Quality of Life and Treatment Satisfaction By Baseline Patient Characteristics: Pooled Results from Two Randomized Phase 3 Studies of Ruxolitinib Cream for the Treatment of Vitiligo
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.192
https://www.valueinhealthjournal.com/article/S1098-3015(22)00393-X/fulltext
Title :
CO96 Subgroup Analysis of Quality of Life and Treatment Satisfaction By Baseline Patient Characteristics: Pooled Results from Two Randomized Phase 3 Studies of Ruxolitinib Cream for the Treatment of Vitiligo
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00393-X&doi=10.1016/j.jval.2022.04.192
First page :
Section Title :
Open access? :
No
Section Order :
10158